|
2026
|
G/S
|
Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obe... |
|
|
G/S
|
Pharmaceutical preparations and substances; medical preparations; vaccines. |
|
|
G/S
|
Pharmaceutical and medicinal preparations and substances;
vaccines. |
|
|
G/S
|
Pharmaceutical preparations for use as antiinfectives; pharmaceutical preparations for the treatm... |
|
2025
|
Invention
|
Antigen binding proteins.
Antigen binding proteins and fragments thereof which specifically bind... |
|
|
Invention
|
Combinations of muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist.
Combinations... |
|
2024
|
Invention
|
Modified proteins and peptides.
The present invention relates to modified proteins and peptides ... |
|
2023
|
Invention
|
Combinations of a muscarinic receptor antagonist and a β-2 adrenoreceptor agonist. Combinations o... |
|
2022
|
Invention
|
Dry powder inhalation drug products exhibiting moisture control properties and methods of adminis... |
|
|
Invention
|
Antigen binding proteins. The present invention concerns antigen binding proteins and fragments t... |
|
2021
|
Invention
|
Label set for an inhalation device |
|
|
Invention
|
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist.
Combinatio... |
|
|
Invention
|
Modulation of hepatitis b virus (hbv) expression.
Disclosed herein are antisense compounds and m... |
|
2020
|
Invention
|
Antigen binding proteins to oncostatin m (osm).
The present invention concerns antigen binding p... |
|
|
Invention
|
Anti-serum albumin binding variants.
The invention relates to improved variants of the anti-seru... |
|
|
Invention
|
Compounds. The invention is directed to compounds of formula (I):
and salts thereof. The compou... |
|
|
Invention
|
Compositions and methods for modulating hbv expression.
Provided herein are oligomeric compounds... |
|
2019
|
Invention
|
Medicament dispenser.
An inhalation device having at least one elongate medicament carrier inclu... |
|
2018
|
Invention
|
Method of treatment with humanized anti-il-18 antibodies. The present invention discloses humanis... |
|
2017
|
Invention
|
Antigen binding proteins.
The present invention concerns antigen binding proteins and fragments ... |
|
|
Invention
|
Ligands that bind tgf-beta receptor ii.
The disclosure provides an anti-TGFbetaRII immunoglobuli... |
|
|
Invention
|
2-(azaindol-2-yl) benzimidazoles as pad4 inhibitors. 1-6alkyl; and salts thereof are PAD4 inhibit... |
|
|
Invention
|
Compositions and methods for modulating ttr expression. Provided herein are oligomeric compounds ... |
|
|
Invention
|
Methods for selecting protease resistant polypeptides. The disclosure relates to a method for sel... |
|
|
Invention
|
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist. Combination... |
|
|
Invention
|
Positive allosteric modulators of human melanocortin-4 receptor. Disclosed herein are positive al... |
|
|
Invention
|
Process for separation of oligonucleotide of interest from a mixture.
A method for separation of... |
|
|
Invention
|
2 substituted cephem compounds. The compounds of the subject invention are related to 2-substitut... |
|
|
Invention
|
Novel compounds.
The invention is directed to methods of treatment using compounds of formula (I... |
|
|
Invention
|
Antigen binding proteins to oncostatin m (osm). The present invention concerns antigen binding pr... |
|
|
Invention
|
Anti-serum albumin binding variants. The invention relates to improved variants of the anti-serum... |
|
2016
|
Invention
|
Novel compounds.
The present invention is directed to novel retinoid-related orphan receptor gam... |
|
|
Invention
|
2-(azaindol-2-yl) benzimidazoles as pad4 inhibitors. Compounds of formula (I):
and salts thereo... |
|
|
Invention
|
Immunoglobulins.
The present invention discloses humanised anti-IL-18 antibodies, methods of man... |
|
|
Invention
|
Antigen binding constructs.
The present invention is directed to antigen binding constructs comp... |
|
|
Invention
|
Inhaler device |
|
|
Invention
|
Treatment for vitiligo.
A method of treating vitiligo, including prophylaxis, in a subject in ne... |
|
|
Invention
|
Treatment for vitiligo. A method of treating vitiligo, including prophylaxis, in a subject in nee... |
|
|
Invention
|
Method of producing a recombinant protein. The present invention relates to a method of producing... |
|
2015
|
Invention
|
Child-proof package.
A package which can be torn open by a user, comprising a polymer film mater... |
|
2014
|
Invention
|
Novel milk beverage composition comprising creatine.
Ready to drink milk beverage compositions a... |
